Circulating LncRNAs Serve as Diagnostic Markers for Hepatocellular Carcinoma

Cellular Physiology and Biochemistry

Volumn 44, Issue 1, 2017, Pages 125-132

  Yuan, Weidong ^a   Sun, Yong ^a   Liu, Ling ^a   Zhou, Bing ^a   Wang, Shuming ^a   Gu, Dianhua ^a  

^a THE AFFILIATED HUAIAN NO 1 PEOPLE S HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

AUC; Fingerprint; Hcc; LncRNA; Plasma

Indexed keywords

ALPHA FETOPROTEIN; LONG UNTRANSLATED RNA; LONG UNTRANSLATED RNA LINC00152; LONG UNTRANSLATED RNA LOC149086; LONG UNTRANSLATED RNA RP11 160H22.5; LONG UNTRANSLATED RNA XLOC014172; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER DIAGNOSIS; CHRONIC HEPATITIS; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE MARKER; FEMALE; GENETIC SCREENING; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INDEPENDENT VARIABLE; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RECEIVER OPERATING CHARACTERISTIC; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK SCORE ANALYSIS; RNA FINGERPRINTING; SCORING SYSTEM; SENSITIVITY AND SENSIBILITY; VALIDATION STUDY; AREA UNDER THE CURVE; BLOOD; CASE CONTROL STUDY; COMPLICATION; GENETICS; HEPATITIS; LIVER TUMOR; METABOLISM; REAL TIME POLYMERASE CHAIN REACTION;

ALPHA-FETOPROTEINS; AREA UNDER CURVE; BIOMARKERS, TUMOR; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; FEMALE; HEPATITIS; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; REAL-TIME POLYMERASE CHAIN REACTION; RNA, LONG NONCODING; ROC CURVE;

EID: 85033462799     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000484589     Document Type: Article

References (31)

1. Chaisaingmongkol J, Budhu A, Dang H, Rabibhadana S, Pupacdi B, Kwon SM, Forgues M, Pomyen Y, Bhudhisawasdi V, Lertprasertsuke N, Chotirosniramit A, Pairojkul C, Auewarakul CU, Sricharunrat T, Phornphutkul K, Sangrajrang S, Cam M, He P, Hewitt SM, Ylaya K, Wu X, Andersen JB, Thorgeirsson SS, Waterfall JJ, Zhu YJ, Walling J, Stevenson HS, Edelman D, Meltzer PS, Loffredo CA, Hama N, Shibata T, Wiltrout RH, Harris CC, Mahidol C, Ruchirawat M, Wang XW, Consortium T-L: Common Molecular Subtypes Among Asian Hepatocellular Carcinoma and Cholangiocarcinoma. Cancer Cell 2017;32:57-60.
2. Logan GJ, Dane AP, Hallwirth CV, Smyth CM, Wilkie EE, Amaya AK, Zhu E, Khandekar N, Ginn SL, Liao SHY, Cunningham SC, Sasaki N, Cabanes-Creus M, Tam PPL, Russell DW, Lisowski L, Alexander IE: Identification of liver-specific enhancer-promoter activity in the 3' untranslated region of the wild-type AAV2 genome. Nat Genet 2017;49:1268-1273.
3. Cancer Genome Atlas Research Network. Electronic address wbe, Cancer Genome Atlas Research N: Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma. Cell 2017;169:1327-1341.
4. El-Khoueiry AB, Sangro B, Yau T, Crocenzi TS, Kudo M, Hsu C, Kim TY, Choo SP, Trojan J, Welling THR, Meyer T, Kang YK, Yeo W, Chopra A, Anderson J, Dela Cruz C, Lang L, Neely J, Tang H, Dastani HB, Melero I: Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): An open-label, noncomparative, phase 1/2 dose escalation and expansion trial. Lancet 2017;389:2492-2502.
5. Chan SL, Wong VW, Qin S, Chan HL: Infection and Cancer: The Case of Hepatitis B. J Clin Oncol 2016;34:83-90.
6. Liu Y, Chai Y, Zhang J, Tang J: A Function Variant at miR-501 Alters Susceptibility to Hepatocellular Carcinoma in a Chinese Han Population. Cell Physiol Biochem 2016;38:2500-2508.
7. Wang Y, He L, Du Y, Zhu P, Huang G, Luo J, Yan X, Ye B, Li C, Xia P, Zhang G, Tian Y, Chen R, Fan Z: The long noncoding RNA lncTCF7 promotes self-renewal of human liver cancer stem cells through activation of Wnt signaling. Cell Stem Cell 2015;16:413-425.
8. Lau CC, Sun T, Ching AK, He M, Li JW, Wong AM, Co NN, Chan AW, Li PS, Lung RW, Tong JH, Lai PB, Chan HL, To KF, Chan TF, Wong N: Viral-human chimeric transcript predisposes risk to liver cancer development and progression. Cancer Cell 2014;25:335-349.
9. Cao C, Sun J, Zhang D, Guo X, Xie L, Li X, Wu D, Liu L: The long intergenic noncoding RNA UFC1, a target of MicroRNA 34a, interacts with the mRNA stabilizing protein HuR to increase levels of beta-catenin in HCC cells. Gastroenterology 2015;148:415-426 e418.
10. Hong X, Kim ES, Guo H: Epigenetic Regulation of Hepatitis B Virus Covalently Closed Circular DNA: Implications for Epigenetic Therapy against Chronic Hepatitis B. Hepatology 2017. Doi:10.1002/hep.29479
11. Yang Y, Chen L, Gu J, Zhang H, Yuan J, Lian Q, Lv G, Wang S, Wu Y, Yang YT, Wang D, Liu Y, Tang J, Luo G, Li Y, Hu L, Sun X, Wang D, Guo M, Xi Q, Xi J, Wang H, Zhang MQ, Lu ZJ: Recurrently deregulated lncRNAs in hepatocellular carcinoma. Nat Commun 2017;8:14421.
12. Li D, Liu X, Zhou J, Hu J, Zhang D, Liu J, Qiao Y, Zhan Q: Long noncoding RNA HULC modulates the phosphorylation of YB-1 through serving as a scaffold of extracellular signal-regulated kinase and YB-1 to enhance hepatocarcinogenesis. Hepatology 2017;65:1612-1627.
13. Yang F, Zhang L, Huo XS, Yuan JH, Xu D, Yuan SX, Zhu N, Zhou WP, Yang GS, Wang YZ, Shang JL, Gao CF, Zhang FR, Wang F, Sun SH: Long noncoding RNA high expression in hepatocellular carcinoma facilitates tumor growth through enhancer of zeste homolog 2 in humans. Hepatology 2011;54:1679-1689.
14. Yuan JH, Liu XN, Wang TT, Pan W, Tao QF, Zhou WP, Wang F, Sun SH: The MBNL3 splicing factor promotes hepatocellular carcinoma by increasing PXN expression through the alternative splicing of lncRNA-PXNAS1. Nat Cell Biol 2017;19:820-832.
15. Rizvi AH, Camara PG, Kandror EK, Roberts TJ, Schieren I, Maniatis T, Rabadan R: Single-cell topological RNA-seq analysis reveals insights into cellular differentiation and development. Nat Biotechnol 2017;35:551-560.
16. Liu M, Xing LQ, Liu YJ: A three-long noncoding RNA signature as a diagnostic biomarker for differentiating between triple-negative and non-triple-negative breast cancers. Medicine (Baltimore) 2017;96:e6222.
17. Abraham JM, Meltzer SJ: Long Noncoding RNAs in the Pathogenesis of Barrett's Esophagus and Esophageal Carcinoma. Gastroenterology 2017;153:27-34.
18. Ren S, Wang F, Shen J, Sun Y, Xu W, Lu J, Wei M, Xu C, Wu C, Zhang Z, Gao X, Liu Z, Hou J, Huang J, Sun Y: Long non-coding RNA metastasis associated in lung adenocarcinoma transcript 1 derived miniRNA as a novel plasma-based biomarker for diagnosing prostate cancer. Eur J Cancer 2013;49:2949-2959.
19. Tang J, Zhuo H, Zhang X, Jiang R, Ji J, Deng L, Qian X, Zhang F, Sun B: A novel biomarker Linc00974 interacting with KRT19 promotes proliferation and metastasis in hepatocellular carcinoma. Cell Death Dis 2014;5:e1549.
20. Yip TC, Chan HL, Wong VW, Tse YK, Lam KL, Wong GL: Impact of age and gender on risk of hepatocellular carcinoma after hepatitis B surface antigen seroclearance. J Hepatol 2017. Doi:10.1016/j.jhep.2017.06.019
21. Lai Q, Vitale A, Iesari S, Finkenstedt A, Mennini G, Spoletini G, Hoppe-Lotichius M, Vennarecci G, Manzia TM, Nicolini D, Avolio AW, Frigo AC, Cillo U, Graziadei I, Rossi M, Tsochatzis E, Otto G, Ettorre GM, Tisone G, Vivarelli M, Agnes S, Lerut J, European Hepatocellular Cancer Liver Transplant Study G: Intention-totreat survival benefit of liver transplantation in patients with hepatocellular cancer. Hepatology 2017. Doi:10.1002/hep.29342
22. Dutta R, Mahato RI: Recent advances in hepatocellular carcinoma therapy. Pharmacol Ther 2017;173:106-117.
23. Devaux Y, Zangrando J, Schroen B, Creemers EE, Pedrazzini T, Chang CP, Dorn GW, 2nd, Thum T, Heymans S, Cardiolinc n: Long noncoding RNAs in cardiac development and ageing. Nat Rev Cardiol 2015;12:415-425.
24. Xu N, Chen F, Wang F, Lu X, Wang X, Lv M, Lu C: Clinical significance of high expression of circulating serum lncRNA RP11-445H22.4 in breast cancer patients: A Chinese population-based study. Tumour Biol 2015;36:7659-7665.
25. Yuan SX, Wang J, Yang F, Tao QF, Zhang J, Wang LL, Yang Y, Liu H, Wang ZG, Xu QG, Fan J, Liu L, Sun SH, Zhou WP: Long noncoding RNA DANCR increases stemness features of hepatocellular carcinoma by derepression of CTNNB1. Hepatology 2016;63:499-511.
26. Zhou M, Zhang XY, Yu X: Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma. Biomed Pharmacother 2017;85:348-354.
27. Li J, Wang X, Tang J, Jiang R, Zhang W, Ji J, Sun B: HULC and Linc00152 Act as Novel Biomarkers in Predicting Diagnosis of Hepatocellular Carcinoma. Cell Physiol Biochem 2015;37:687-696.
28. Konishi H, Ichikawa D, Yamamoto Y, Arita T, Shoda K, Hiramoto H, Hamada J, Itoh H, Fujita Y, Komatsu S, Shiozaki A, Ikoma H, Ochiai T, Otsuji E: Plasma level of metastasis-associated lung adenocarcinoma transcript 1 is associated with liver damage and predicts development of hepatocellular carcinoma. Cancer Sci 2016;107:149-154.
29. El-Tawdi AH, Matboli M, Shehata HH, Tash F, El-Khazragy N, Azazy Ael S, Abdel-Rahman O: Evaluation of Circulatory RNA-Based Biomarker Panel in Hepatocellular Carcinoma. Mol Diagn Ther 2016;20:265-277.
30. Tang J, Jiang R, Deng L, Zhang X, Wang K, Sun B: Circulation long non-coding RNAs act as biomarkers for predicting tumorigenesis and metastasis in hepatocellular carcinoma. Oncotarget 2015;6:4505-4515.
31. Thai P, Statt S, Chen CH, Liang E, Campbell C, Wu R: Characterization of a novel long noncoding RNA, SCAL1, induced by cigarette smoke and elevated in lung cancer cell lines. Am J Respir Cell Mol Biol 2013;49:204-211.